Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer reorg continues with corporate communications exec

Executive Summary

Former White House Communications Director Loretta Ucelli has been named senior VP-corporate communications for Pfizer effective Aug. 29. In the new position she will be responsible for the company's communications platform and will be one of three people reporting to Vice Chairman Jeffrey Kindler, who added corporate affairs to his purview earlier this year when Pfizer announced a restructuring of its upper management (1"The Pink Sheet" Feb. 28, 2005, p. 20). Senior VP-Corporate Affairs Chuck Hardwick left the company June 25. Ucelli most recently served as exec VP-communications and external affairs for Columbia University...

You may also be interested in...



Pfizer Streamlines Upper Management; Katen Positioned As Heir Apparent

Pfizer's newly created corporate executive committee streamlines the company's top management structure

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046180

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel